Skip to main content
. 2020 Dec 24;6(3):853–856. doi: 10.1016/j.ekir.2020.12.006

Figure 2.

Figure 2

Evolution of serum creatinine (mg/dl) over time with actinium-225 (225Ac)–prostate-specific membrane antigen (PSMA)617 therapy for patient 1 (a) and patient 2 (b).